| Species |
Bovine |
| Protein Construction |
IL-6 (Gly30-Lys208)
Accession # P26892 |
|
| Purity |
≥ 95% as analyzed by SDS-PAGE |
| Endotoxin Level |
< 0.2 EU/μg of protein by gel clotting method |
| Expression System |
E.coli |
| Theoretical Molecular Weight |
20.7 kDa |
| Apparent Molecular Weight |
~ 20.9 kDa, on SDS-PAGE under reducing conditions |
| Formulation |
Lyophilized from a 0.2 μm filtered solution in PBS, pH 7.4 |
| Reconstitution |
Before opening, centrifuge the vial briefly to bring the contents to the bottom. Reconstitute the lyophilized powder in ddH2O up to 100 μg/ml |
| Storage & Stability |
Upon receiving, this product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable up to 1 week at 4 °C or up to 3 months at -20 °C or below. Avoid repeated freeze-thaw cycles. |
Lane 1: 2 µg of IL-6, Bovine under reducing condition (R)
Lane 2: 2 µg of IL-6, Bovine under non-reducing condition (NR) (N)
The purity is greater than 95% as analyzed by SDS-PAGE
| Target Background |
Interleukin-6 (IL-6), also known as BSF-2, CDF and IFNB2, is a pleiotropic cytokine. IL-6 participates in both pro-inflammatory and anti-inflammatory responses. IL-6 is produced mainly by T cells, macrophages and muscle cells. It stimulates B cell differentiation and antibody production, and cell differentiation. |
| Synonyms |
Interleukin-6;IL-6; |
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.
